Radius Health, Inc

(NASDAQ:RDUS)

Latest On Radius Health, Inc (RDUS):

Date/Time Type Description Signal Details
2024-04-19 05:52 ESTDividendA dividend of $0.19 has been announced on Apr 1, 2024. It will be paid May 6, 2024 with an ex-dividend date of Apr 19, 2024.Neutral
2024-02-02 04:53 ESTDividendA dividend of $0.19 has been announced on Jan 4, 2024. It will be paid Feb 20, 2024 with an ex-dividend date of Feb 2, 2024.Neutral
2023-11-10 04:52 ESTDividendA dividend of $0.19 has been announced on Oct 25, 2023. It will be paid Nov 27, 2023 with an ex-dividend date of Nov 10, 2023.Neutral
2022-08-11 14:35 ESTNewsRadius stock rises as elacestrant gets FDA priority review to treat breast cancer subtypeN/A
2022-06-23 18:53 ESTNewsRadius Health jumps 14% on $890M buyout offerN/A
2022-06-23 00:58 ESTNewsMenarini Group, Radius Health seek FDA approval for breast cancer treatment elacestrantN/A
2022-06-17 00:30 ESTNewsRadius Health gains over 10% as major investor backs board changesN/A
2022-06-08 23:53 ESTNewsRadius Health expands non-U.S. market footprint for its Tymlos injectionN/A
2022-06-01 19:48 ESTNewsRadius Health to end development of Tymlos osteoporosis patch; shares down 6%N/A
2022-05-20 04:01 ESTNewsRadius Health breast cancer drug elacestrant meets primary endpoint in late-stage trialN/A
2022-05-12 23:57 ESTNewsRadius Health, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-07 06:46 ESTNewsRadius Health, Inc. (RDUS) CEO Kelly Martin On Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 08:39 ESTNewsRadius Health Q1 2022 Earnings PreviewN/A
2022-05-05 08:37 ESTNewsRadius Health Non-GAAP EPS of -$0.19 misses by $0.01, revenue of $43.16M misses by $8.13MN/A
2022-03-16 09:43 ESTNewsRadius Health names Mark Conley as CFON/A
2022-03-01 11:51 ESTNewsRadius Health files sNDA for osteoporosis drug Tymlos in menN/A
2022-02-24 17:54 ESTNewsRadius Health Non-GAAP EPS of $0.05 misses by $0.03, revenue of $65.1M beats by $2.04MN/A
2022-02-24 17:53 ESTNewsRadius Health, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2022-02-24 17:53 ESTNewsReevaluating Radius HealthN/A
2022-02-24 17:53 ESTNewsRadius Health, Inc.'s (RDUS) CEO Kelly Martin on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 00:59 ESTNewsRadius Health Q4 2021 Earnings PreviewN/A
2022-01-13 20:06 ESTNewsRadius Health sheds 20% of non-sales headcountN/A
2021-12-23 19:07 ESTNewsRadius wins FDA approval to remove boxed warning on osteoporosis drugN/A
2021-12-17 09:07 ESTNewsRadius Health up ~4% as owner buys 462,238 sharesN/A
2021-12-14 20:35 ESTNewsWarning: RDUS is at high risk of performing badlyN/A
2021-12-10 21:11 ESTNewsRadius Health cut to Neutral at Goldman Sachs on failed osteoporosis studyN/A
2021-12-10 21:10 ESTNewsRadius cut to underweight at Morgan Stanley given abaloparatide patch study missN/A
2021-12-10 01:41 ESTNewsRadius Health price target cut at H.C. Wainwright on setback to osteoporosis trialN/A
2021-12-09 06:57 ESTNewsRadius Health continues fall following phase 3 osteoporosis trial miss; shares off 44%N/A
2021-12-08 12:03 ESTNewsRadius Health says late-stage osteoporosis study did not meet main goalN/A
2021-11-08 17:41 ESTNewsRadius Health EPS misses by $0.24, misses on revenueN/A
2021-11-08 17:40 ESTNewsRadius Health shares fall after Q3 earnings missN/A
2021-11-08 17:40 ESTNewsRadius Pharmaceuticals, Inc. (RDUS) CEO Kelly Martin on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 17:40 ESTNewsRadius Health, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-06 07:27 ESTNewsRadius Health Q3 2021 Earnings PreviewN/A
2021-10-24 06:12 ESTNewsMeiraGTx, Aurinia among healthcare gainers this week; Jasper slips after twofold riseN/A
2021-10-21 15:27 ESTNewsRadius Health price target raised on Wall Street after trial win for breast cancer drugN/A
2021-10-20 14:23 ESTNewsRadius Health shares surge 34% on results from late-stage elacestrant breast cancer studyN/A
2021-10-18 19:52 ESTNewsRadius Health to seek FDA nod for subcutaneous TYMLOS in 2022 after trial successN/A
2021-09-28 00:39 ESTNewsWarning: RDUS has been downgraded to Very BearishN/A
2021-09-28 00:28 ESTNewsRadius Health gains 7% as owner buys more sharesN/A
2021-09-23 10:44 ESTNewsWarning: RDUS has been downgraded to Very Bearish.N/A
2021-08-07 23:51 ESTNewsRadius Health, Inc. (RDUS) CEO Kelly Martin on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 09:26 ESTNewsRadius Health, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-08-05 12:02 ESTNewsRadius Health EPS misses by $0.03, misses on revenueN/A
2021-07-27 15:20 ESTNewsRadius sees 40% growth in Tymlos prescriptions in Q2 2021N/A
2021-07-23 05:31 ESTNewsRadius Health updates plans for late-stage Prader-Willi Syndrome studyN/A
2021-05-07 14:21 ESTNewsRadius Health EPS misses by $0.02, misses on revenueN/A
2021-04-22 21:20 ESTNewsRadius sees patient growth with osteoporosis drug Tymlos in Q1N/A
2021-04-15 06:58 ESTNewsRadius Health: Commercial Stage Company With Late-Stage Assets, But Pipeline Lacks DiversityN/A

About Radius Health, Inc (RDUS):

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

RDUS Quotes by TradingView

See Advanced Chart

General

  • Name Radius Health, Inc
  • Symbol RDUS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 310
  • Last Split Factor1:2
  • Last Split Date2014-04-24
  • Fiscal Year EndDecember
  • IPO Date2014-06-06
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.radiuspharm.com
View More

Valuation

  • Forward PE 66.23
  • Price/Sales (Trailing 12 Mt.) 4.52
  • Enterprise Value Revenue 5.1
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.85
  • Next Year EPS Estimate $0.59
  • Next Quarter EPS Estimate -$0.42
  • Profit Margin -46%
  • Operating Margin -35%
  • Return on Assets -25%
  • Revenue 238.64 million
  • Earnings Per Share -$3.70
  • Revenue Per Share $5.14
  • Gross Profit 222.24 million
  • Quarterly Earnings Growth 12.8%
View More

Highlights

  • Market Capitalization 1.03 billion
  • EBITDA -146914000
  • PE Ratio -7.74
  • PEG Ratio -0.16
  • Analyst Target Price $23.14
View More

Share Statistics

  • Shares Outstanding 46.89 million
  • Shares Float 46.76 million
  • % Held by Insiders 20%
  • % Held by Institutions 105.91%
  • Shares Short 5.91 million
  • Shares Short Prior Month 5.65 million
  • Short Ratio 15.23
  • Short % of Float 17%
  • Short % of Shares Outstanding 13%
View More

Technicals

  • Beta 0.93
  • 52 Week High $23.84
  • 52 Week Low $10.15
  • 50 Day Moving Average 20.55
  • 200 Day Moving Average 16.65
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 4.13%
View More

Radius Health, Inc (RDUS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Radius Health, Inc (RDUS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$62.78 million-$0.23-$0.14-60.84%
2020-09-302020-11-05$77.83 million$0.15-$0.05383.55%
2020-06-302020-08-10$N/A-$0.67-$0.51-31.37%
2020-03-312020-05-07$N/A-$0.59-$0.54-8.6%
2019-12-312020-02-27$55.67 million-$0.29-$0.4940.51%
2019-09-302019-11-05$46.77 million-$0.65-$0.7310.96%
2019-06-302019-08-07$41.04 million-$0.77-$0.76-1.67%
2019-03-312019-05-08$29.84 million-$0.94-$0.82-14.63%
2018-12-312019-02-28$34.42 million-$0.81-$1.1227.08%
2018-09-302018-11-01$27.64 million-$1.00-$1.2821.92%
2018-06-302018-08-07$22.63 million-$1.18-$1.3412.16%
2018-03-312018-05-10$14.55 million-$1.37-$1.465.93%
2017-12-312018-03-01$7.66 million-$1.59-$1.43-10.94%
2017-09-302017-11-02$13.47 million-$1.31-$1.28-2.08%
2017-06-302017-08-03$980000-$1.58-$1.23-28.32%
2017-03-312017-05-01$N/A-$1.32-$1.18-11.63%
2016-12-312017-02-23$N/A-$1.22-$1.316.95%
2016-09-302016-11-03$N/A-$1.07-$1.070%
2016-06-302016-08-04$N/A-$1.01-$1.00-1.44%
2016-03-312016-05-05$N/A-$0.94-$0.75-25%
2015-12-312016-02-25$N/A-$0.77-$0.63-22.22%
2015-09-302015-11-05$N/A-$0.68-$0.57-19.3%
2015-06-302015-08-06$N/A-$0.61-$0.52-17.31%
2015-03-312015-05-06$N/A-$0.47-$0.529.62%
2014-12-312015-03-10$N/A-$0.55-$0.6312.7%
2014-09-302014-11-10$N/A-$0.59-$0.659.23%
2014-06-302014-08-12$N/A-$2.19-$0.89-146.07%

Radius Health, Inc (RDUS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Radius Health, Inc (RDUS) Chart:

Radius Health, Inc (RDUS) News:

Below you will find a list of latest news for Radius Health, Inc (RDUS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Radius Health, Inc (RDUS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17512.3CALL1 02.96TRUE00
2024-05-17154.95CALL5 31.05TRUE2.5-0.51
2024-05-1717.52.35CALL61 20.5TRUE1.45-0.62
2024-05-17200.45CALL21 1080FALSE0.440
2024-05-1722.50.15CALL2 590FALSE0.06-0.4
2024-05-17250.25CALL3 140.44FALSE1.40
2024-05-17300.15CALL10 1860FALSE0.290
2024-05-17350.05CALL10 1720.13FALSE0.060
2024-05-17400.36CALL2 70FALSE0.350
2024-05-17450.35CALL 10.41FALSE0.350
2024-05-17150.2PUT1 280.88FALSE0.10
2024-05-1717.50.85PUT80 1250.53FALSE0.10.65
2024-05-17201.1PUT16 330.13TRUE0.650
2024-05-1722.55PUT1 440.06TRUE0.210
2024-05-17255.96PUT13 150.48TRUE0.350
2024-05-17306.3PUT1 10TRUE0.130
2024-08-1612.56.4CALL10 100.96TRUE6.40
2024-08-16154.7CALL1 00.71TRUE4.70
2024-08-1617.53.6CALL1 60.62TRUE0.20
2024-08-16202.3CALL61 1050.5FALSE0.10
2024-08-1622.50.75CALL3 1200.45FALSE0.750
2024-08-16251.05CALL1 2020.57FALSE0.390
2024-08-16304.6CALL12 10.45FALSE4.60
2024-08-16350.2CALL1 500.42FALSE0.270
2024-08-16401.16CALL1 10.43FALSE00
2024-08-1612.50.25PUT 20.59FALSE0.250
2024-08-16150.8PUT5 1120.53FALSE0.050
2024-08-1617.51.65PUT3 2350.5FALSE1.350.45
2024-08-16202.25PUT7 130.49TRUE0.150
2024-08-1622.53.9PUT5 60.47TRUE3.710
2024-08-16255.8PUT10 10.4TRUE2.10
2024-08-16303.1PUT 50.4TRUE3.10
2024-09-202.517.2CALL2 22.76TRUE17.20
2024-09-2012.55.4CALL 0.68TRUE5.40
2024-09-2017.53.8CALL1 5152.85TRUE0.90
2024-09-20202.3CALL6 1950.47FALSE00
2024-09-2022.51.6CALL20 2254.12FALSE00
2024-09-20251CALL1 1846.41FALSE0.050
2024-09-20300.45CALL1 2243.07FALSE00
2024-09-20350.2CALL10 1643.9FALSE2.190
2024-09-20400.1CALL32 9340.28FALSE0.150
2024-09-20500.37CALL3 344.32FALSE00
2024-09-2012.50.44PUT2 20.58FALSE0.440
2024-09-20150.7PUT235 2760.48FALSE0.30
2024-09-2017.51.85PUT28 39651.51FALSE0.650
2024-09-20203.4PUT98 22150.2TRUE0.950
2024-09-2022.53.91PUT20 8942.89TRUE00
2024-09-20255PUT4 7145.28TRUE2.30
2024-09-20304.85PUT15 1540.31TRUE00
2024-09-20356.9PUT85 9541.14TRUE00
2024-09-205019.9PUT0 138.89TRUE00
2024-11-15108.72CALL 160.73TRUE8.720
2024-11-1512.56.75CALL18 190.56TRUE7.80
2024-11-15154.23CALL1 50.55TRUE4.230
2024-11-15202.91CALL2 10.5FALSE2.910
2024-11-1522.52.1CALL1 10.49FALSE1.80
2024-11-15251.45CALL1 870.47FALSE0.90
2024-11-15300.69CALL10 200.48FALSE0.690
2024-11-15350.33CALL20 210.49FALSE0.160
2024-11-1512.50.67PUT5 780.56FALSE0.220
2024-11-15151.05PUT37 450.53FALSE0.10
2024-11-15203.09PUT11 340.48TRUE2.50
2024-11-1522.50PUT 80.51TRUE4.280
2024-11-15255.8PUT 40.72TRUE5.80
2024-09-20450CALL0 044.01FALSE00
2024-09-20400PUT0 039.98TRUE00
2024-09-20450PUT0 037.9TRUE00

Latest RDUS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$6.855
Jun 13, 2022 7:59 PM EST1$6.86
Jun 13, 2022 7:59 PM EST100$6.86
Jun 13, 2022 7:59 PM EST1$6.86
Jun 13, 2022 7:59 PM EST200$6.86

Radius Health, Inc (RDUS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520175726/0001193125-20-175726-index.htm
2018-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000008025518002797/0000080255-18-002797-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000008025519002673/0000080255-19-002673-index.htm
2019-11-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000008025519002992/0000080255-19-002992-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000008025520001270/0000080255-20-001270-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000009375119000103/0000093751-19-000103-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000009375120000409/0000093751-20-000409-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000021545719005790/0000215457-19-005790-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000031506619001301/0000315066-19-001301-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000083423720006873/0000834237-20-006873-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000089914019000218/0000899140-19-000218-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924318022027/0000899243-18-022027-index.htm
2018-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924318022543/0000899243-18-022543-index.htm
2018-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924318022966/0000899243-18-022966-index.htm
2018-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924318031191/0000899243-18-031191-index.htm
2018-12-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924318031549/0000899243-18-031549-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924319003965/0000899243-19-003965-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924319026963/0000899243-19-026963-index.htm
2020-05-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924320011906/0000899243-20-011906-index.htm
2020-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924320018807/0000899243-20-018807-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924320024980/0000899243-20-024980-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000089924320025283/0000899243-20-025283-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000090221919000365/0000902219-19-000365-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000090221920000049/0000902219-20-000049-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000090221920000369/0000902219-20-000369-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000093247119005993/0000932471-19-005993-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000108514619000744/0001085146-19-000744-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000110465920017825/0001104659-20-017825-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000110465920020755/0001104659-20-020755-index.htm
2018-08-16SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000114420418045140/0001144204-18-045140-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000114420419007537/0001144204-19-007537-index.htm
2018-08-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1428522/000119312518246182/0001193125-18-246182-index.htm
2018-08-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1428522/000119312518263607/0001193125-18-263607-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520123248/0001193125-20-123248-index.htm
2020-05-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1428522/000119312520145785/0001193125-20-145785-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520175726/0001193125-20-175726-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520197805/0001193125-20-197805-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520214137/0001193125-20-214137-index.htm
2020-09-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520238156/0001193125-20-238156-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520252861/0001193125-20-252861-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000119312520286265/0001193125-20-286265-index.htm
2018-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919118049621/0001209191-18-049621-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919118049624/0001209191-18-049624-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919118063053/0001209191-18-063053-index.htm
2019-01-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119005311/0001209191-19-005311-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119005314/0001209191-19-005314-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009729/0001209191-19-009729-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009734/0001209191-19-009734-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009739/0001209191-19-009739-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009745/0001209191-19-009745-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009753/0001209191-19-009753-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009760/0001209191-19-009760-index.htm
2019-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009775/0001209191-19-009775-index.htm
2019-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009779/0001209191-19-009779-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009783/0001209191-19-009783-index.htm
2019-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009789/0001209191-19-009789-index.htm
2019-02-135Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119009800/0001209191-19-009800-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013698/0001209191-19-013698-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013699/0001209191-19-013699-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013701/0001209191-19-013701-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013704/0001209191-19-013704-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013706/0001209191-19-013706-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013710/0001209191-19-013710-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013712/0001209191-19-013712-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013715/0001209191-19-013715-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013718/0001209191-19-013718-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013720/0001209191-19-013720-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013722/0001209191-19-013722-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119013735/0001209191-19-013735-index.htm
2019-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119017351/0001209191-19-017351-index.htm
2019-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119024476/0001209191-19-024476-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119025249/0001209191-19-025249-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119025252/0001209191-19-025252-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119025254/0001209191-19-025254-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119029406/0001209191-19-029406-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119036015/0001209191-19-036015-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919119041027/0001209191-19-041027-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120009592/0001209191-20-009592-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012138/0001209191-20-012138-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012139/0001209191-20-012139-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012144/0001209191-20-012144-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012146/0001209191-20-012146-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012148/0001209191-20-012148-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012151/0001209191-20-012151-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012152/0001209191-20-012152-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012153/0001209191-20-012153-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012155/0001209191-20-012155-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012156/0001209191-20-012156-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120012186/0001209191-20-012186-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120013789/0001209191-20-013789-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120013790/0001209191-20-013790-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120013792/0001209191-20-013792-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120013793/0001209191-20-013793-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120013794/0001209191-20-013794-index.htm
2020-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120013795/0001209191-20-013795-index.htm
2020-04-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120026150/0001209191-20-026150-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120026151/0001209191-20-026151-index.htm
2020-08-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120046368/0001209191-20-046368-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120046375/0001209191-20-046375-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1428522/000120919120054092/0001209191-20-054092-index.htm
2018-08-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1428522/000121465918005605/0001214659-18-005605-index.htm
2018-09-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000131924418000054/0001319244-18-000054-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000131924419000021/0001319244-19-000021-index.htm
2019-06-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000131924419000052/0001319244-19-000052-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1428522/000131924420000041/0001319244-20-000041-index.htm
2018-09-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459018023377/0001564590-18-023377-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459018025998/0001564590-18-025998-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019000301/0001564590-19-000301-index.htm
2019-01-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019001104/0001564590-19-001104-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019005448/0001564590-19-005448-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1428522/000156459019011988/0001564590-19-011988-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1428522/000156459019011990/0001564590-19-011990-index.htm
2019-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019014392/0001564590-19-014392-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019016831/0001564590-19-016831-index.htm
2019-05-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1428522/000156459019018024/0001564590-19-018024-index.htm
2019-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019022047/0001564590-19-022047-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019030042/0001564590-19-030042-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019040372/0001564590-19-040372-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459019046550/0001564590-19-046550-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020000925/0001564590-20-000925-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020007025/0001564590-20-007025-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020011890/0001564590-20-011890-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020012999/0001564590-20-012999-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020013701/0001564590-20-013701-index.htm
2020-04-17DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1428522/000156459020017261/0001564590-20-017261-index.htm
2020-04-17DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1428522/000156459020017268/0001564590-20-017268-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020022889/0001564590-20-022889-index.htm
2020-05-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1428522/000156459020023562/0001564590-20-023562-index.htm
2020-06-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1428522/000156459020028620/0001564590-20-028620-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828018010589/0001628280-18-010589-index.htm
2018-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828018013236/0001628280-18-013236-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1428522/000162828019002275/0001628280-19-002275-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828019006186/0001628280-19-006186-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828019010286/0001628280-19-010286-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828019013328/0001628280-19-013328-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1428522/000162828020002354/0001628280-20-002354-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828020006972/0001628280-20-006972-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828020012243/0001628280-20-012243-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1428522/000162828020015691/0001628280-20-015691-index.htm
2018-08-23CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1428522/999999999718007434/9999999997-18-007434-index.htm
2020-05-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1428522/999999999720003006/9999999997-20-003006-index.htm

Radius Health, Inc (RDUS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Radius Health, Inc (RDUS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 20%
Institutional Ownership: 10591%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-22Anthony RosenbergDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013720/0001209191-19-013720-index.htm
2019-02-22CATHY FRIEDMANDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013699/0001209191-19-013699-index.htm
2019-02-22Debasish RoychowdhuryDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013722/0001209191-19-013722-index.htm
2019-02-22JEAN PIERRE GARNIERDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013701/0001209191-19-013701-index.htm
2019-02-22Kurt GravesDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013704/0001209191-19-013704-index.htm
2019-02-22Owen HughesDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013712/0001209191-19-013712-index.htm
2019-02-22Willard H DereDirectorBuy5,500.0010,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013698/0001209191-19-013698-index.htm
2020-02-26Owen HughesDirectorSell2,750.0017.9549,362.5010,650.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120013795/0001209191-20-013795-index.htm
2020-02-20Kurt GravesDirectorBuy5,500.0011,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012146/0001209191-20-012146-index.htm
2020-02-26Willard H DereDirectorSell1,925.0017.9534,553.7512,195.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120013790/0001209191-20-013790-index.htm
2020-02-26Anthony RosenbergDirectorSell1,815.0017.9532,579.2512,401.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120013792/0001209191-20-013792-index.htm
2019-03-05Jessica HopfieldDirectorBuy12,800.0019.23246,190.0812,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119017351/0001209191-19-017351-index.htm
2019-02-22Joseph Francis KellySr. VP of Sales and MarketingBuy10,000.0013,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013715/0001209191-19-013715-index.htm
2020-02-20Owen HughesDirectorBuy5,500.0013,400.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012152/0001209191-20-012152-index.htm
2020-02-20Willard H DereDirectorBuy5,500.0014,120.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012139/0001209191-20-012139-index.htm
2020-02-20Anthony RosenbergDirectorBuy5,500.0014,216.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012156/0001209191-20-012156-index.htm
2019-02-22Charles Q MorrisChief Medical OfficerBuy15,000.0015,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013718/0001209191-19-013718-index.htm
2020-02-20CATHY FRIEDMANDirectorBuy5,500.0015,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012186/0001209191-20-012186-index.htm
2020-02-20JEAN PIERRE GARNIERDirectorBuy5,500.0015,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012144/0001209191-20-012144-index.htm
2019-02-22Brent Hatzis-SchochSr. VP, General CounselBuy15,000.0017,944.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013706/0001209191-19-013706-index.htm
2019-02-22Jose CarmonaChief Financial OfficerBuy15,000.0018,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119013735/0001209191-19-013735-index.htm
2020-02-20Jessica HopfieldDirectorBuy5,500.0018,300.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012151/0001209191-20-012151-index.htm
2020-02-26Joseph Francis KellySr. VP of Sales and MarketingSell889.0017.9315,942.4424,111.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120013794/0001209191-20-013794-index.htm
2020-02-20Joseph Francis KellySr. VP of Sales and MarketingBuy17,500.0025,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012153/0001209191-20-012153-index.htm
2018-12-17Joseph Francis KellySr. VP of Sales and MarketingBuy3,000.0015.7147,130.003,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919118063053/0001209191-18-063053-index.htm
2020-02-26Charles Q MorrisChief Medical OfficerSell1,256.0017.9322,523.8533,744.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120013793/0001209191-20-013793-index.htm
2020-02-20Charles Q MorrisChief Medical OfficerBuy20,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012155/0001209191-20-012155-index.htm
2020-02-26Jose CarmonaChief Financial OfficerSell1,292.0017.9323,169.4446,708.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120013789/0001209191-20-013789-index.htm
2019-02-13Anthony RosenbergDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009760/0001209191-19-009760-index.htm
2019-02-13CATHY FRIEDMANDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009734/0001209191-19-009734-index.htm
2019-02-13Debasish RoychowdhuryDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009783/0001209191-19-009783-index.htm
2019-02-13JEAN PIERRE GARNIERDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009739/0001209191-19-009739-index.htm
2019-02-13Kurt GravesDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009745/0001209191-19-009745-index.htm
2019-02-13Owen HughesDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009753/0001209191-19-009753-index.htm
2019-02-13Willard H DereDirectorBuy4,800.004,800.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119009729/0001209191-19-009729-index.htm
2020-02-20Jose CarmonaChief Financial OfficerBuy30,000.0048,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919120012138/0001209191-20-012138-index.htm
2019-05-10Joseph Francis KellySr. VP of Sales and MarketingBuy2,000.0021.4342,860.005,000.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119029406/0001209191-19-029406-index.htm
2019-04-11Debasish RoychowdhuryDirectorSell4,800.0022.15106,320.005,500.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119024476/0001209191-19-024476-index.htm
2019-04-16Kurt GravesDirectorSell4,800.0022.32107,136.005,500.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119025252/0001209191-19-025252-index.htm
2018-08-08GROWTH N V BIOTECH10% Share HolderBuy60,000.0022.731,363,884.006,360,913.00https://www.sec.gov/Archives/edgar/data/1428522/000089924318022027/0000899243-18-022027-index.htm
2018-08-14GROWTH N V BIOTECH10% Share HolderBuy100,000.0020.872,086,880.006,460,913.00https://www.sec.gov/Archives/edgar/data/1428522/000089924318022543/0000899243-18-022543-index.htm
2018-08-15GROWTH N V BIOTECH10% Share HolderBuy69,363.0020.781,441,529.616,530,276.00https://www.sec.gov/Archives/edgar/data/1428522/000089924318022543/0000899243-18-022543-index.htm
2018-08-20GROWTH N V BIOTECH10% Share HolderBuy60,000.0019.651,178,808.006,590,276.00https://www.sec.gov/Archives/edgar/data/1428522/000089924318022966/0000899243-18-022966-index.htm
2018-12-14GROWTH N V BIOTECH10% Share HolderBuy60,000.0015.64938,256.006,650,276.00https://www.sec.gov/Archives/edgar/data/1428522/000089924318031191/0000899243-18-031191-index.htm
2018-12-20GROWTH N V BIOTECH10% Share HolderBuy60,000.0014.48868,782.006,710,276.00https://www.sec.gov/Archives/edgar/data/1428522/000089924318031549/0000899243-18-031549-index.htm
2019-11-06GROWTH N V BIOTECH10% Share HolderBuy100,000.0023.002,300,300.006,881,685.00https://www.sec.gov/Archives/edgar/data/1428522/000089924319026963/0000899243-19-026963-index.htm
2020-04-30TARGET N V BIOTECH10% Share HolderBuy50,000.0015.75787,555.006,931,685.00https://www.sec.gov/Archives/edgar/data/1428522/000089924320011906/0000899243-20-011906-index.htm
2020-07-08TARGET N V BIOTECH10% Share HolderBuy25,000.0013.21330,177.506,956,685.00https://www.sec.gov/Archives/edgar/data/1428522/000089924320018807/0000899243-20-018807-index.htm
2020-09-11TARGET N V BIOTECH10% Share HolderBuy199,029.0011.332,255,117.997,155,714.00https://www.sec.gov/Archives/edgar/data/1428522/000089924320024980/0000899243-20-024980-index.htm
2020-09-14TARGET N V BIOTECH10% Share HolderBuy200,000.0011.692,338,680.007,355,714.00https://www.sec.gov/Archives/edgar/data/1428522/000089924320025283/0000899243-20-025283-index.htm
2019-06-07Joseph Francis KellySr. VP of Sales and MarketingBuy2,500.0021.8154,536.007,500.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119036015/0001209191-19-036015-index.htm
2019-04-16Owen HughesDirectorSell2,400.0022.2253,328.007,900.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119025254/0001209191-19-025254-index.htm
2019-04-16Willard H DereDirectorSell1,680.0022.2237,329.608,620.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119025249/0001209191-19-025249-index.htm
2019-07-01Anthony RosenbergDirectorSell1,584.0024.6038,966.408,716.00https://www.sec.gov/Archives/edgar/data/1428522/000120919119041027/0001209191-19-041027-index.htm